GSK CANADA AND THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE SIGN LETTER OF INTENT FOR BLENREP FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Reuters · 3d ago

Please log in to view news